Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Galapagos NV (GLPG)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create a new watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
63.69 -0.24    -0.38%
11:36:07 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Netherlands
ISIN:  BE0003818359 
  • Volume: 250,188
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 62.92 - 64.33
Galapagos 63.69 -0.24 -0.38%

GLPG Analysis

 
This page features the latest analysis and reports for the Galapagos NV stock.
 
Next
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GLPG Comments

Write your thoughts about Galapagos NV
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bryan The Crystal Ball
Bryan The Crystal Ball May 27, 2021 10:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Update: it looks like it broke out of the falling wedge. The odds of this going higher are better now
Reply
0 0
Report
Jan Hendrickx
Jan Hendrickx May 07, 2021 8:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
nice job on profit! now a beautiful takeover. I'm guessing Pharming Group
Reply
1 1
Report
Ludo Huibers
Ludo Huibers May 06, 2021 3:26PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
no earnings today? or they failed even on that???
Reply
0 0
Report
Black Berry aRmY
Black Berry aRmY Apr 28, 2021 5:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
45$ is a good entry point
Reply
1 2
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Feb 23, 2021 1:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
161410494356645.jpg
This trash is going to 32 Euro. Have fun!
Reply
4 3
Report
Jan Hendrickx
Jan Hendrickx Feb 23, 2021 1:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ooh, u bougt in too high?
Reply
0 1
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Feb 23, 2021 1:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Jan Hendrickx  no
Reply
0 0
Report
FA SA
FA SA Feb 22, 2021 6:44PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ready for takeover?!
Reply
2 1
Report
FA SA
FA SA Feb 22, 2021 6:43PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It makes for a good takeover now!
Reply
0 0
Report
Robert Jacketti
Robert Jacketti Feb 15, 2021 11:03AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Verkopen die boel - teveel vraagtekens. Wat ben je met hoop cash als je bedrijf een holle doos is...
Reply
2 2
Report
Nathan de jong
Nathan de jong Feb 15, 2021 7:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Geen enkel medicijn meer op de plank wat verkoopbaar is.
Reply
1 3
Report
Jan Hendrickx
Jan Hendrickx Feb 15, 2021 7:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wel 5 miljard cash waarmee ze overnames kunnen doen 😏
Reply
0 1
Report
Fab Pi
FabP Feb 03, 2021 10:41AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
guys, any good news that could wake up this one? I had it on red when it went downs 18.5% in a day.... is long way ...
Reply
0 0
Report
Pascal Neder
Pascal Neder Feb 03, 2021 10:41AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
RIP
Reply
5 2
Report
Lode Schepers
andretti3 Jan 14, 2021 4:01PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Enig nieuws omtrent de voordracht en reacties op conference bij JP morgan?
Reply
0 0
Report
Maya Normusbut
Maya Normusbut Jan 08, 2021 10:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
zelfde koers als vorig jaar , 1 groot verschil is dat ze nu wel omzet draaien. ik zie dit aandeel niet verder zakken.
Reply
2 0
Report
Robby Cuijpers
Robby Cuijpers Jan 08, 2021 10:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ze kunnen dus nog dieper zakken -18.72% weer
Reply
1 0
Report
dennis foster
dennis foster Jan 08, 2021 10:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
66.10 nu
Reply
0 0
Report
Marc Meert
Marc Meert Jan 08, 2021 10:11AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
58 nu
Reply
0 0
Report
Tony De Witte
Tony De Witte Dec 29, 2020 3:15AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Zijn alle vertrouwen kwijt in galapagos. Zal een lange weg zijn voor men er terug vertrouwen in krijgt. Als de ceo ook aandelen verkoopt voor het aandeel 20% zakt en dan terug koopt
Reply
0 1
Report
Werner van Dongen
Werner van Dongen Dec 29, 2020 3:15AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
waardeloos management. Niks communiceren omtrent Halloweenmeeting. Dan zelf cashen ondanks het feit dat aandelen 40% van ATH stond. En nu instappen. Hoop echt dat de VEB hier vol achter aan gaan. Onno en zijn oplichtersbende
Reply
0 1
Report
Marc Meert
Marc Meert Dec 29, 2020 3:15AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
@ Tony: dat heb ik eigenhandig meer CEO's zien doen hoor; Je zou nog verschieten wie
Reply
0 0
Report
Jesse De Vroede
Jesse De Vroede Nov 09, 2020 6:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought at 122, long term goal (+-1y) 150
Reply
5 1
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Nov 09, 2020 6:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You should sell it when you can and invest in the American stock market. There is too much regulation here that keeps the market down. Stocks like these go up big on speculation, but decline a lot on failed medicine.
Reply
2 1
Report
Bryan The Crystal Ball
Bryan The Crystal Ball Nov 09, 2020 6:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Check out Nio, Palantir technologies for huge profits or Tesla for a safer bet. The future is in full self drive. Also check out what Cathy Wood says. Everything she invests in turns to gold.
Reply
1 0
Report
Victor Den Ouden
Victor Den Ouden Nov 09, 2020 6:38AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Long term goal
Reply
0 0
Report
Umut Saglam
Umut Saglam Sep 14, 2020 3:27AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What a POS!! It drops suddenly
Reply
0 0
Report
Maya Normusbut
Maya Normusbut Sep 14, 2020 3:27AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
you must be new to this?
Reply
1 0
Report
Umut Saglam
Umut Saglam Sep 02, 2020 3:07AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Man this should recover back to 120-130 at least. It is still a reputable bio company
Reply
3 0
Report
Ovidijus Ovidijus
Ovidis Aug 20, 2020 3:17AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
so what was the reason of that deep..?Earnings looks like expected.. did company failed on some research ?
Reply
0 0
Report
Jesse De Vroede
Jesse De Vroede Aug 20, 2020 3:17AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
one of their products did not get cleared by FDA
Reply
0 0
Report
Commodity Trader
Commodity Trader Aug 19, 2020 8:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what a scam this stock, never believes CEOs is the lesson
Reply
0 0
Report
Umut Saglam
Umut Saglam Aug 19, 2020 6:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Would buy the dip apply here? :D
Reply
0 0
Report
Umut Saglam
Umut Saglam Aug 19, 2020 5:57AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
My God :o
Reply
2 0
Report
Carlos Andres
Carlos Andres Aug 19, 2020 4:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what a deep fall!
Reply
0 0
Report
Manu Pela
Manu Pela Aug 19, 2020 3:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ouch
Reply
2 0
Report
Philip Martens
Philip Martens Aug 04, 2020 4:45AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
small volume.
Reply
0 0
Report
Umut Saglam
Umut Saglam Aug 04, 2020 3:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Such random bs. While everything is green, this is red
Reply
0 0
Report
Mad Mushroom
MadMushroom Jul 24, 2020 8:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://www.ema.europa.eu/en/medicines/human/summaries-opinion/jyseleca On 23 July 2020, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Jyseleca, intended for the treatment of rheumatoid arthritis. The applicant for this medicinal product is Gilead Sciences Ireland UC. Jyseleca will be available as 100 mg and 200 mg film-coated tablets. The active substance of Jyseleca is filgotinib, an immunosuppressants (ATC code: L04AA45). Filgotinib is an adenosine triphosphate (ATP) competitive and reversible inhibitor of the Janus kinase (JAK) family.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email